| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.3 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |